Chris Scott

Full Professor

University of Ottawa

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Chris Scott is a Full Professor at the University of Ottawa, Canada. His research areas include pediatric rheumatology, childhood-onset lupus, and the management of rheumatic diseases. He has contributed to various international consensus definitions and recommendations, particularly focusing on the implications of maternal and child health. His recent articles examine clinical practices in pediatric rheumatology and the impact of immunomodulating treatments.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Christian M. Hedrich

UNITED KINGDOM

View details

Joan Bailey-Wilson

Co-Branch Chief

National Human Genome Research Institute

UNITED STATES

View details

Helen Foster

Head of Clinical Dept, Paediatric Rheumatology

Newcastle University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chris Scott

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Preface: Pediatric rheumatology

Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force

Transmission disequilibrium analysis of whole genome data in childhood-onset systemic lupus erythematosus

Conflicts of interest are harming maternal and child health: time for scientific journals to end relationships with manufacturers of breast-milk substitutes

Paediatric non-infectious uveitis in Cape Town, South Africa: a retrospective review of disease characteristics and outcomes on immunomodulating treatment

Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions.

Open-Label Phase 3 Study of Intravenous Golimumab in Patients With Polyarticular Juvenile Idiopathic Arthritis.

Revising the WHO Essential Medicines List for paediatric rheumatology.

African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.

Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019.

Collaborators (3)

Christian M. Hedrich

Joan Bailey-Wilson

Helen Foster

Make your next move.